文章摘要
李凡,肖波飞,宋敏,熊维建,雷蕾,王开振,龙梅,丁伟森.柴胡加龙骨牡蛎汤加减通过p38 MAPK通路改善CKD小鼠PFC突触可塑性及抑郁行为研究[J].南京中医药大学学报,2021,37(6):878-885.
柴胡加龙骨牡蛎汤加减通过p38 MAPK通路改善CKD小鼠PFC突触可塑性及抑郁行为研究
Modified Chaihu Longgu Muli Decoction Improved the Synaptic Plasticity of PFC and Alleviated the Depressive Symptoms in CKD Mice via p38 MAPK Pathway
  
DOI:
中文关键词: 关键词:慢性肾脏病  抑郁  炎症  突触可塑性  柴胡加龙骨牡蛎汤加减;p38 MAPK
英文关键词: chronic kidney disease  depression  inflammation  synaptic plasticity  modified Chaihu Longgu Muli Decoction  p38 MAPK

基金项目:
作者单位
李凡1,肖波飞2,宋敏3,熊维建1,雷蕾1,王开振1,龙梅1,丁伟森1 1.重庆市中医院肾内科重庆 400021
2.湖南省中医药研究院附属医院湖南 长沙 410006
3.重庆医科大学第二附属医院重庆 400010 
摘要点击次数: 17
全文下载次数: 84
中文摘要:
      目的 探讨柴胡加龙骨牡蛎汤加减(CLMD)对慢性肾脏病(CKD)小鼠抑郁行为的作用及可能机制。方法 3月龄雄性C57BL/6小鼠60只,分为对照组、模型组、氟西汀组、CLMD低剂量组、CLMD中剂量组和CLMD高剂量组。除对照组外,其余5组小鼠先予0.2%腺嘌呤饮食喂养2周。中药干预组分别予2.36、4.725、9.45 g·kg-1·d-1的CLMD灌胃,氟西汀组予10 mg·kg-1·d-1氟西汀灌胃,对照组、模型组予生理盐水灌胃,共计6周。糖水偏好测试、强迫游泳实验检测小鼠抑郁行为表型,Western blot法检测前额叶皮层(PFC) p38丝裂原活化蛋白激酶(p38 MAPK)、磷酸化p38 MAPK(p-p38 MAPK)、脑源性神经营养因子(BDNF)、环磷腺苷效应元件结合蛋白(CREB)、磷酸化CREB(p-CREB)、突触后致密蛋白95(PSD95)、突触素(SYN)、生长相关蛋白43(GAP43)和突触囊泡膜蛋白(SYP)表达;免疫荧光法检测PFC脑区核内p-CREB的表达;Golgi-Cox染色检测PFC树突棘密度;ELISA法检测外周及PFC炎性因子水平及血清肌酐、尿素氮水平。结果 行为学检测结果显示:与对照组相比,模型组不动时间增加,糖水偏好指数下降(P<0.01);与模型组相比,给予中、高剂量CLMD干预后小鼠不动时间下降(P<0.01),糖水偏好指数增加(P<0.05,P<0.01),CLMD中、高剂量组与氟西汀组之间差异无统计学意义(P>0.05)。Western blot结果显示:与对照组相比,模型组小鼠PFC中p-p38 MAPK/p38 MAPK表达增加(P<0.01),BDNF、p-CREB/CREB、PSD95、SYN、GAP43、SYP表达下调(P<0.01);与模型组相比,CLMD中、高剂量组,氟西汀组小鼠p-p38 MAPK/p38 MAPK表达下调(P<0.01),BDNF、p-CREB/CREB、PSD95、SYN、GAP43、SYP表达增加(P<0.01)。免疫荧光结果显示:与对照组相比,模型组PFC的p-CREB核内荧光水平明显降低(P<0.01);与模型组相比,CLMD中、高剂量组,氟西汀组p-CREB核内荧光强度增加(P<0.05,P<0.01)。Golgi-Cox染色结果显示:与对照组相比,模型组小鼠PFC树突棘密度降低(P<0.01);与模型组相比,CLMD中、高剂量组,氟西汀组小鼠PFC树突棘密度增加(P<0.01)。ELISA法检测结果显示:与对照组相比,模型组PFC及外周血清中炎性因子水平增加(P<0.01),血清尿素氮、肌酐水平增加(P<0.01);与模型组相比,氟西汀组及CLMD中、高剂量组PFC及外周血清中炎性因子水平下降(P<0.05,P<0.01),CLMD中、高剂量组血清尿素氮、肌酐水平下降(P<0.05,P<0.01),氟西汀组尿素氮、肌酐水平无明显变化。结论 CLMD能调节中枢炎症状态,改善PFC突触可塑性,减轻CKD小鼠抑郁症状,同时可能通过影响外周炎症状态延缓CKD小鼠肾脏功能恶化。
英文摘要:
      OBJECTIVE To study the effect and mechanism of modified Chaihu Longgu Muli Decoction (CLMD) on depressive behavior in chronic kidney disease (CKD) mice. METHODS Sixty 3-month-old male C57BL/6 mice were divided into control group, model group, fluoxetine group, CLMD low dose group, CLMD medium dose group and CLMD high dose group. Except the control group, the rest 5 groups of mice were intervened by 0.2% adenine diet for 2 weeks, then CLMD low, medium, high groups were gavaged 2.36, 4.725, 9.45 g·kg-1·d-1 of CLMD, respectively. Fluoxetine group was given 10 mg·kg-1·d-1 fluoxetine by gavage, while the control group and model group were given the same amount of normal saline, for six weeks. Sugar preference test and forced swimming test were used to evaluate the depressive state of mice, Western blot was used to detect the expressions of p38 mitogen-activated protein kinase (p38 MAPK), phosphorylated p38 MAPK (p-p38 MAPK), brain derived neurotrophic factor (BDNF), cAMP-response element binding protein (CREB), phosphorylation CREB (p-CREB), postsynaptic density protein 95 (PSD95), Synapsin (SYN) and growth associated protein 43 (GAP43), Synaptophysin (SYP) proteins in the prefrontal cortex (PFC). The nucleus expression of p-CREB in PFC was detected by immunofluorescence assay, the changes of dendrite spines in PFC were detected by Golgi-Cox staining, and the levels of inflammatory factors in peripheral serum and PFC, and the serum creatinine and urea nitrogen were detected by ELISA assay. RESULTS The behavior test results showed that, compared with the control group, the immobility time of the model group increased and the percentage of sugar preference level decreased (P<0.01). Compared with the model group, the immobility time of mice decreased and the percentage of sugar water preference increased after the intervention of CLMD (P<0.05, P<0.01), there was no significant difference among the medium dose group, the high dose group and fluoxetine group (P>0.05). Western blot results showed that, compared with the control group, the expressions of p-p38 MAPK/p38 MAPK in PFC of the model group increased (P<0.01), and the expressions of BDNF, p-CREB/CREB, PSD95, SYN, GAP43 and SYP down-regulated (P<0.01). Compared with the model group, the relative expressions of p-p38 MAPK/p38 MAPK in medium-dose, high-dose groups and fluoxetine group down-regulated (P<0.01), and the relative expressions of BDNF, p-CREB/CREB, PSD95, SYN, GAP43 and SYP increased (P<0.01). Immunofluorescence results showed that, compared with the control group, the nuclear fluorescence level of p-CREB in PFC of the model group significantly decreased (P<0.01). Compared with the model group, the nuclear fluorescence expression of p-CREB increased in medium-dose, high-dose groups and fluoxetine group (P<0.05, P<0.01). The results of Golgi-Cox staining showed that the number of PFC dendritic spines in model group was lower than that in control group (P<0.01). Compared with the model group, the numbers of PFC dendritic spines increased after medium-dose, high-dose CLMD and fluoxetine intervention (P<0.01). ELISA results showed that, compared with the control group, the levels of inflammatory factors in both peripheral blood and PFC of model group increased (P<0.01), the levels of serum urea nitrogen and creatinine increased (P<0.01). Compared with model group, after medium-dose, high-dose CLMD intervention, the levels of pro-inflammatory factors, serum urea nitrogen and creatinine in PFC and peripheral blood decreased (P<0.05, P<0.01). CONCLUSION CLMD can alleviate the depressive symptoms of CKD mice by regulating the inflammatory state of the central nervous system and affecting the synaptic plasticity of PFC. Meanwhile, CLMD can delay the deterioration of kidney function in CKD model mice by regulating the inflammatory state of the peripheral.
查看全文   查看/发表评论  下载PDF阅读器
关闭
微信公众号